PlexusDx clinicians review your current dose and response history to recommend an equivalent starting point
To reduce this risk, double-check your calculations and consider using a calculator or a specific application created for dose administration
Nearly 42% of adults struggle with weight management, yet many delay GLP-1 therapy because they lack insurance coverage
Ipamorelin adjustments are based on symptoms and lab markers: If sleep and recovery improve at 200 mcg, you may stay at that dose If you want more pronounced GH effects, your physician may increase to 250 to 300 mcg A second daily dose (morning, fasted) can be added for enhanced GH support If water retention or joint stiffness develops, the dose may be reduced Key lab work at the 6 to 8 week mark: IGF-1 (confirms Ipamorelin is producing a GH response) thorough metabolic panel HbA1c and fasting glucose Lipid panel Lab work and monitoring Phase 4: Sustained Progress (Weeks 12 through 24) By this stage, both peptides are dialed in and working together effectively
Lower levels of glutathione have been linked to various health concerns, including fatigue, weakened immune response, and impaired detoxification ability